316 related articles for article (PubMed ID: 20109651)
41. A novel Asp344Val substitution in the fibrinogen gamma chain (fibrinogen Caen) causes dysfibrinogenemia associated with thrombosis.
Robert-Ebadi H; Le Querrec A; de Moerloose P; Gandon-Laloum S; Borel Derlon A; Neerman-Arbez M
Blood Coagul Fibrinolysis; 2008 Oct; 19(7):697-9. PubMed ID: 18832913
[TBL] [Abstract][Full Text] [Related]
42. Fibrinogen geneva II: a new congenitally abnormal fibrinogen alpha chain (Gly17Asp) with a review of similar mutations resulting in abnormal knob A.
Casini A; De Maistre E; Casini-Stuppi V; Fontana P; Neerman-Arbez M; de Moerloose P
Blood Coagul Fibrinolysis; 2014 Apr; 25(3):280-2. PubMed ID: 24389539
[TBL] [Abstract][Full Text] [Related]
43. Retrochorionic hematoma in congenital afibrinogenemia: resolution with fibrinogen concentrate infusions.
Aygören-Pürsün E; Martinez Saguer I; Rusicke E; Louwen F; Geka F; Ivaskevicius V; Oldenburg J; Klingebiel T; Kreuz W
Am J Hematol; 2007 Apr; 82(4):317-20. PubMed ID: 17034026
[TBL] [Abstract][Full Text] [Related]
44. Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology.
Levi M; Toh CH; Thachil J; Watson HG
Br J Haematol; 2009 Apr; 145(1):24-33. PubMed ID: 19222477
[TBL] [Abstract][Full Text] [Related]
45. Inherited abnormalities of fibrinogen: 10-year clinical experience of an Italian group.
Santacroce R; Cappucci F; Pisanelli D; Perricone F; Papa ML; Santoro R; Grandone E; Margaglione M
Blood Coagul Fibrinolysis; 2006 Jun; 17(4):235-40. PubMed ID: 16651864
[TBL] [Abstract][Full Text] [Related]
46. [Dysfibrinogenemia and thrombosis. A case report].
Kraiem I; Guermazi S; Ben Abid H; Meddeb B
Tunis Med; 2010 Oct; 88(10):757-60. PubMed ID: 20890827
[TBL] [Abstract][Full Text] [Related]
47. Treatment of afibrinogenemia in a chihuahua.
Chambers G
J Am Anim Hosp Assoc; 2013; 49(1):70-4. PubMed ID: 23148136
[TBL] [Abstract][Full Text] [Related]
48. Fibrinogen concentrate and cryoprecipitate but not fresh frozen plasma correct low fibrinogen concentrations following in vitro haemodilution.
Fenger-Eriksen C; Christiansen K; Laurie J; Sørensen B; Rea C
Thromb Res; 2013 May; 131(5):e210-3. PubMed ID: 23473642
[TBL] [Abstract][Full Text] [Related]
49. Treatment of congenital fibrinogen deficiency: overview and recent findings.
Tziomalos K; Vakalopoulou S; Perifanis V; Garipidou V
Vasc Health Risk Manag; 2009; 5():843-8. PubMed ID: 19851522
[TBL] [Abstract][Full Text] [Related]
50. Rotational thromboelastography for monitoring of fibrinogen concentrate therapy in fibrinogen deficiency.
Kalina U; Stöhr HA; Bickhard H; Knaub S; Siboni SM; Mannucci PM; Peyvandi F
Blood Coagul Fibrinolysis; 2008 Dec; 19(8):777-83. PubMed ID: 19002044
[TBL] [Abstract][Full Text] [Related]
51. Laboratory and Genetic Investigation of Mutations Accounting for Congenital Fibrinogen Disorders.
Neerman-Arbez M; de Moerloose P; Casini A
Semin Thromb Hemost; 2016 Jun; 42(4):356-65. PubMed ID: 27019463
[TBL] [Abstract][Full Text] [Related]
52. [Children with hemorrhagic diathesis: correct diagnostic and therapeutic approach].
Carnelli V; Dozzi M; Gibelli M; Giovanniello A; Riva F; Seidita C; Stucchi C
Pediatr Med Chir; 1990; 12(1):1-13. PubMed ID: 2198546
[TBL] [Abstract][Full Text] [Related]
53. [Congenital afibrinogenemia complicated by spontaneous cerebral hemorrhages: a case report].
Tovone XG; Rasamoelisoa JM; Rakotomalala S; Rabesiaka F; Rakotoarimanana DR; Ramialiharisoa A
Arch Inst Pasteur Madagascar; 1999; 65(1-2):117-9. PubMed ID: 12478976
[TBL] [Abstract][Full Text] [Related]
54. Fibrinogen Saint-Germain II: hypofibrinogenemia due to heterozygous gamma N345S mutation.
de Raucourt E; de Mazancourt P; Maghzal GJ; Brennan SO; Mosesson MW
Thromb Haemost; 2005 Nov; 94(5):965-8. PubMed ID: 16363237
[TBL] [Abstract][Full Text] [Related]
55. Dysfibrinogenemia (fibrinogen Wilmington) due to a novel Aalpha chain truncation causing decreased plasma expression and impaired fibrin polymerisation.
Brennan SO; Mosesson MW; Lowen R; Frantz C
Thromb Haemost; 2006 Jul; 96(1):88-9. PubMed ID: 16807657
[No Abstract] [Full Text] [Related]
56. Fibrinogen Nový Jicín and Praha II: cases of hereditary Aalpha 16 Arg-->Cys and Aalpha 16 Arg-->His dysfibrinogenemia.
Kotlín R; Chytilová M; Suttnar J; Riedel T; Salaj P; Blatný J; Santrůcek J; Klener P; Dyr JE
Thromb Res; 2007; 121(1):75-84. PubMed ID: 17408725
[TBL] [Abstract][Full Text] [Related]
57. Fibrinogen Caracas I: a dysfibrinogenemia with a hemorrhagic diathesis associated with diminished fibrin fiber diameter and reduced fibrin gel porosity.
Marchi R; Lundberg U; de Bosch NB; Arocha-Piñango CL
Blood Coagul Fibrinolysis; 1998 Nov; 9(8):733-9. PubMed ID: 9890716
[TBL] [Abstract][Full Text] [Related]
58. Congenital hypofibrinogenemia and recurrent placental abruption.
Ness PM; Budzynski AZ; Olexa SA; Rodvien R
Obstet Gynecol; 1983 Apr; 61(4):519-23. PubMed ID: 6828283
[TBL] [Abstract][Full Text] [Related]
59. Management of acute bleeding in a patient with congenital afibrinogenaemia.
Vakalopoulou S; Rizopoulou D; Zafiriadou E; Perifanis V; Tziomalos K; Lefkou E; Hill M; Dolan G; Garipidou V
Haemophilia; 2006 Nov; 12(6):676-8. PubMed ID: 17083521
[TBL] [Abstract][Full Text] [Related]
60. Plasma-derived biological medicines used to promote haemostasis.
Ofosu FA; Freedman J; Semple JW
Thromb Haemost; 2008 May; 99(5):851-62. PubMed ID: 18449414
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
